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ABSTRACT
Haemophilus inﬂuenzae is an uncommon cause of
bacterial meningitis in adults. This report des-
cribes a prospective evaluation of 16 episodes of
community-acquired H. inﬂuenzae meningitis in a
nationwide study on bacterial meningitis. Predis-
posing conditions were present in eight (50%) of
the 16 episodes; the most common predisposing
conditions were otitis or sinusitis (ﬁve episodes;
31%) and remote neurosurgery or head trauma
(three episodes; 19%). One (6%) episode was fatal
and hearing loss occurred in four (25%) episodes.
It was concluded that H. inﬂuenzae meningitis in
adults is a disease with a rather benign clinical
course and a relatively good prognosis compared
with pneumococcal meningitis.
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Haemophilus inﬂuenzae meningitis occurs sporad-
ically in adults and has been described in small
retrospective case series as a disease following
remote head trauma or neurosurgery, or in
patients with predisposing conditions [1–5]. A
recent report described a prospective nationwide
cohort study in The Netherlands that involved
696 adults with community-acquired bacterial
meningitis [6]. The present report describes the
clinical features, complications and outcome for
adults in the cohort with H. inﬂuenzae menin-
gitis.
The methods used have been described previ-
ously [6]. In brief, eligible patients were aged
>16 years, had bacterial meningitis conﬁrmed by
culture of cerebrospinal ﬂuid (CSF), and were
listed in the database of The Netherlands Refer-
ence Laboratory for Bacterial Meningitis between
October 1998 and April 2002. The treating physi-
cian was contacted and informed consent was
obtained from participating patients or their legal
representatives. The study was also approved by
the local ethics committee. Patients with hospital-
acquired meningitis (deﬁned as meningitis that
occurred during hospitalisation or within 1 week
of discharge), neurosurgical devices and ⁄ or a
history of recent (within 1 month) head trauma
or neurosurgery were excluded. Patients with an
altered immune status caused by use of immu-
nosuppressive drugs, splenectomy, diabetes mell-
itus or alcoholism were considered to be
immunocompromised. Predisposing factors for
developing bacterial meningitis were deﬁned as
otitis, sinusitis, pneumonia, an immunocompro-
mised state, remote neurosurgery and remote
head trauma (occurring ‡1 month before the
onset of meningitis). Patients underwent a neu-
rological examination at discharge, and outcome
was graded with the Glasgow outcome scale.
Complaints of hearing loss were conﬁrmed by an
audiogram examination. All patients with bacter-
ial meningitis and CSF cultures positive for
H. inﬂuenzae were included in this study.
In total, 16 episodes of community-acquired
H. inﬂuenzae meningitis were identiﬁed in 15
patients (Table 1). The calculated annual inci-
dence was 0.04 cases ⁄ 100 000 adults. Predispos-
ing conditions were present in eight (50%) of 16
episodes. The most common predisposing condi-
tions were otitis or sinusitis (ﬁve episodes; 31%)
and remote neurosurgery or head trauma (three
episodes; 19%). A previous episode of meningitis
had occurred for three (19%) of the 16 episodes.
The clinical severity upon presentation was relati-
vely mild, with only one (6%) episode having a
change in mental status (deﬁned as a Glasgow
Table 1. Clinical, laboratory and radiological characteris-
tics upon admission for 16 episodes of community-
acquired Haemophilus inﬂuenzae meningitisa
Characteristic Frequency
Mean age, years (SD) 47 (9)
Male gender, n (%) 9 ⁄ 16 (56%)
Predisposing factors
Immunocompromised state, n (%) 1 ⁄ 16 (6%)
Pneumonia, n (%) 1 ⁄ 16 (6%)
Otitis or sinusitis, n (%) 5 ⁄ 16 (31%)
Remote neurosurgery, n (%)b 3 ⁄ 16 (19%)
Remote head trauma, n (%) 1 ⁄ 16 (6%)
CSF leak, n (%) 1 ⁄ 16 (6%)
Recurrent meningitis, n (%) 3 ⁄ 16 (19%)
Pretreated with antimicrobial agents, n (%) 1 ⁄ 16 (6%)
Duration of symptoms <24 h, n (%) 4 ⁄ 15 (27%)
Seizures, n (%) 0
Symptoms upon presentation
Headache, n ⁄ n evaluated (%) 16 ⁄ 16 (100%)
Nausea, n ⁄ n evaluated 15 ⁄ 16 (94%)
Neck stiffness, n (%) 12 ⁄ 16 (75%)
Fever ‡38C 11 ⁄ 14 (79%)
Glasgow Coma Scale score upon presentation
Median (SD) 15 (0.8)
<14 (indicating change in mental status), n (%) 1 ⁄ 16 (6%)
£8 (indicating coma), n (%) 0
Triad of fever, neck stiffness, and
change in mental status, n (%)
1 ⁄ 16 (6%)
Focal neurological deﬁcits, n (%)
Focal cerebral deﬁcit, n (%)c 0
Cranial nerve palsies, n ⁄ n evaluated (%) 2 ⁄ 16 (12%)
Laboratory examinationd
Indices of CSF inﬂammation
Opening pressure, mm of water 360 (300–480)
White cell count per mm3 3337 (115–38 784)
<100 ⁄mm3, n ⁄ n evaluated (%) 0
100–999 ⁄mm3, n ⁄ n evaluated (%) 1 ⁄ 16 (6%)
>999 ⁄mm3, n ⁄ n evaluated (%) 15 ⁄ 16 (94%)
Protein, g ⁄L 2.58 (1.3–3.8)
CSF ⁄ serum glucose ratio 0.07 (0.0–0.28)
CSF Gram’s stain
Negative 9 ⁄ 15 (60%)
Gram-negative bacilli 5 ⁄ 15 (33%)
Gram-negative cocci 1 ⁄ 15 (7%)
Blood culture
H. inﬂuenzae 6 ⁄ 11 (56%)
Negative 5 ⁄ 11 (44%)
Radiological examination
Computed tomography (CT) brain scan 9 ⁄ 16 (63%)
Abnormal CT brain scan 3e ⁄ 9 (33%)
CT before lumbar puncture 6 ⁄ 9 (67%)
aContinuous data are denoted as the median value (range) unless otherwise stated.
bTwo acoustic neurinomas, one trauma.
cAphasia, monoparesis or hemiparesis.
dCSF pressure was measured in three episodes; CSF white cell count was
determined in 16 episodes; CSF protein concentration was determined in 13
episodes; CSF ⁄ serum glucose ratio was determined in 12 episodes.
ePost-operative defects; sinusitis; combination of a sub-arachnoid cyst and pneu-
matocephalus.
CSF, cerebrospinal ﬂuid.
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Coma Score <14); none of the patients had focal
cerebral deﬁcits upon admission.
All patients underwent a lumbar puncture. At
least one individual CSF ﬁnding predictive of
bacterial meningitis (glucose <1.9 mmol ⁄L, CSF
serum glucose ratio <0.23, protein concentration
>2.20 g ⁄L,white cell count >2000 cells ⁄mm3orCSF
neutrophil count >1180 cells ⁄mm3) [7] was ob-
served in 15 (94%) of the 16 episodes. Complica-
tions developed in a relatively low proportion of
patients (Table 2). One (6%) patient died after
developing hemiparesis, impaired consciousness
and septic shock, but all other patients had a good
recovery. Hearing impairment was found at dis-
charge in four (27%) of 15 episodes, and memory
deﬁcits were reported in one (7%) episode.
Serotyping of H. inﬂuenzae was performed on
15 isolates and revealed one each of serotypes b, e
and f, together with 12 non-typeable isolates. In
one episode, the H. inﬂuenzae isolate was b-lacta-
mase-positive; this isolate was of type b and
caused the only fatal case in this case series. All
cases received adequate microbiological cover by
the initial therapy administered. Adjunctive ster-
oids were given to one patient after clinical
deterioration. One patient was included in the
European Dexamethasone Study and was rand-
omised to the placebo group [8].
Overall, these ﬁndings indicate that H. inﬂuen-
zae meningitis in adults is a relatively benign
disease, especially in comparison with pneumo-
coccal meningitis [6]. Only one patient presented
with a change in mental status, although previous
reports have described impaired consciousness in
a greater proportion (16–67%) of patients with
H. inﬂuenzae meningitis [4,5,9]. The benign char-
acter of this disease was also reﬂected in the low
mortality rate (6%). Predisposing factors were
present in 50% of the episodes, which cor-
responds with a previous description of predis-
posing conditions in 55% of 119 adults with
H. inﬂuenzae meningitis [4]. The high percentage
of patients with anatomical defects and ear
or sinus infections as an underlying cause of
H. inﬂuenzae meningitis justiﬁes consultation with
an otolaryngologist for this patient group.
Most (80%) H. inﬂuenzae isolates in this series
were non-typeable, which corresponds with
epidemiological trends observed after the intro-
duction of Hib vaccination [10–12]. The single
serotype b strain was b-lactamase-positive and
caused sepsis and death, despite adequate anti-
biotic therapy. The most important mechanism of
antibiotic resistance in H. inﬂuenzae involves
b-lactamase production, and occurs in 4–31% of
all H. inﬂuenzae isolates worldwide [13,14].
Empirical therapy for H. inﬂuenzae should include
a third-generation cephalosporin until suscepti-
bility testing has been performed [2,14].
The most common sequela was hearing loss, at
25%. This is an exceptionally high rate and is
much higher than that described for children with
H. inﬂuenzae meningitis [15,16]. A meta-analysis
of children with H. inﬂuenzae meningitis found
that adjunctive dexamethasone treatment was
associated with a decline in the rate of hearing
impairment [17]. In adults with bacterial menin-
gitis, adjunctive dexamethasone therapy has now
been established clearly to be beneﬁcial
[2,8,18,19]. Since this study was performed before
routine use of dexamethasone in adults with
bacterial meningitis, only one patient received
treatment with dexamethasone, which was
prompted by clinical deterioration.
This study has several limitations. First, only
patients with a positive CSF culture were inclu-
ded [1,6]. However, the clinical presentation in
patients with positive and negative CSF cultures
was similar to that in previous studies [1,20]. In
patients found to have space-occupying lesions
following computed tomography scan, or with
coagulation disorders or severe septic shock,
lumbar puncture might not be performed or
might be postponed, which can result in negative
CSF cultures [6]. Therefore, these patient groups
Table 2. Therapy, complications during admission and
outcome of cases of adult Haemophilus inﬂuenzaemeningitis
Characteristic Frequency (%)
Therapy
Penicillin or amoxycillin 7 ⁄ 16 (44%)
Third-generation cephalosporin 4 ⁄ 16 (25%)
Combination 3 ⁄ 16 (19%)
Other 2 ⁄ 16 (13%)
Complications
Cardiorespiratory failure 1 ⁄ 16 (6%)
Mechanical ventilation 1 ⁄ 16 (6%)
Seizures 1 ⁄ 16 (6%)
Impaired consciousness 4 ⁄ 16 (25%)
Hemiparesis 1 ⁄ 16 (6%)
Hearing impairment 4 ⁄ 16 (25%)
Scores on the Glasgow Coma score
1 (death) 1 ⁄ 16 (6%)
2 (vegetative state) 0 ⁄ 16
3 (severe disability) 0 ⁄ 16
4 (moderate disability) 0 ⁄ 16
5 (mild or no disability) 15 ⁄ 16 (94%)
Sequelae at discharge
Hemiparesis 0 ⁄ 15
Hearing impairment 4 ⁄ 15 (27%)
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were probably only partly represented in the
study.
In conclusion, H. inﬂuenzae meningitis in adults
is a disease with a rather benign clinical course
and a relatively good prognosis, especially when
compared with pneumococcal meningitis. Many
adults with H. inﬂuenzae meningitis have predis-
posing conditions, and the need to consult an
otolaryngologist concerning these patients is
emphasised.
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